+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Brain Biomarkers Market Research Report by Product (Biomarker Analyzers and Biomarker Test Kits), Indication, End-Users, Application, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 227 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 4791736
UP TO OFF until Mar 31st 2023
The Global Brain Biomarkers Market size was estimated at USD 7,598.72 million in 2022, USD 8,947.24 million in 2023, and is projected to grow at a CAGR of 17.88% to reach USD 28,337.38 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Brain Biomarkers Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Brain Biomarkers Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Brain Biomarkers Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Brain Biomarkers Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Brain Biomarkers Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Biomarker Analyzers and Biomarker Test Kits.
  • Based on Indication, the market is studied across Alzheimer's Disease, Huntington's Disease, MND & ALS, Parkinson's Disease, and Stroke.
  • Based on End-Users, the market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Hospitals, and Research Laboratories.
  • Based on Application, the market is studied across Diagnosis and Drug Discovery & Development.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Brain Biomarkers Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Brain Biomarkers Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Brain Biomarkers Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Brain Biomarkers Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Brain Biomarkers Market, including Advanced Brain Monitoring, Inc, Biognosys AG, BrainScope Company, Inc., F. Hoffmann-La Roche AG, GE Healthcare, Johnson & Johnson, Lifesign LLC, Magstim EGI, Merck KGaA,, Natus Medical Inc., NeuroVista Corporation, Nexus-DX, PhenoSwitch Bioscience, Seimens Healthnineers, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Brain Biomarkers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Brain Biomarkers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Brain Biomarkers Market?
4. What is the competitive strategic window for opportunities in the Global Brain Biomarkers Market?
5. What are the technology trends and regulatory frameworks in the Global Brain Biomarkers Market?
6. What is the market share of the leading vendors in the Global Brain Biomarkers Market?
7. What modes and strategic moves are considered suitable for entering the Global Brain Biomarkers Market?
Frequently Asked Questions about the Global Brain Biomarkers Market

What is the estimated value of the Global Brain Biomarkers Market?

The Global Brain Biomarkers Market was estimated to be valued at $7598.72 Million in 2022.

What is the growth rate of the Global Brain Biomarkers Market?

The growth rate of the Global Brain Biomarkers Market is 17.8%, with an estimated value of $28337.38 Million by 2030.

What is the forecasted size of the Global Brain Biomarkers Market?

The Global Brain Biomarkers Market is estimated to be worth $28337.38 Million by 2030.

Who are the key companies in the Global Brain Biomarkers Market?

Key companies in the Global Brain Biomarkers Market include Advanced Brain Monitoring, Inc, Biognosys AG, BrainScope Company, Inc., F. Hoffmann, La Roche AG, GE Healthcare, Johnson & Johnson, Lifesign LLC and Merck KGaA,.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Improved knowledge of neurologic diseases and R&D investment to treat growing geriatric population with brain disorder
5.1.1.2. Need for invasive brain tastings, effective drug development, faster diagnosis, and new treatment option
5.1.1.3. Detection and interpretation to support clinical decisions and patient interventions
5.1.2. Restraints
5.1.2.1. Lack of consumer awareness
5.1.3. Opportunities
5.1.3.1. Evolving biomarker data management platforms to support biomarker-guided drug development and translational research
5.1.3.2. Incorporation of detectable parameters with brain biomarkers to improve clinical decision making
5.1.4. Challenges
5.1.4.1. Complexity of neuroinflammation exacerbated by substantial biological heterogeneity
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization
5.8.1. Product Development Pipeline

6. Brain Biomarkers Market, by Product
6.1. Introduction
6.2. Biomarker Analyzers
6.3. Biomarker Test Kits

7. Brain Biomarkers Market, by Indication
7.1. Introduction
7.2. Alzheimer's Disease
7.3. Huntington's Disease
7.4. MND & ALS
7.5. Parkinson's Disease
7.6. Stroke

8. Brain Biomarkers Market, by End-Users
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Laboratories
8.4. Hospitals
8.5. Research Laboratories

9. Brain Biomarkers Market, by Application
9.1. Introduction
9.2. Diagnosis
9.3. Drug Discovery & Development

10. Americas Brain Biomarkers Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Brain Biomarkers Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Brain Biomarkers Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Product Portfolio Analysis, By Key Player
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Advanced Brain Monitoring, Inc
14.2. Biognosys AG
14.3. BrainScope Company, Inc.
14.4. F. Hoffmann-La Roche AG
14.5. GE Healthcare
14.6. Johnson & Johnson
14.7. Lifesign LLC
14.8. Magstim EGI
14.9. Merck KGaA,
14.10. Natus Medical Inc.
14.11. NeuroVista Corporation
14.12. Nexus-DX
14.13. PhenoSwitch Bioscience
14.14. Seimens Healthnineers
14.15. Thermo Fisher Scientific Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL BRAIN BIOMARKERS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL BRAIN BIOMARKERS MARKET DYNAMICS
FIGURE 11. GLOBAL BRAIN BIOMARKERS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 15. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER ANALYZERS, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TEST KITS, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 18. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2030
FIGURE 20. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE , 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HUNTINGTON'S DISEASE, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MND & ALS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
FIGURE 25. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
FIGURE 26. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USERS, 2030
FIGURE 28. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
FIGURE 30. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 31. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
FIGURE 32. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 33. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 34. GLOBAL BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 35. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
FIGURE 36. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
FIGURE 37. AMERICAS BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 39. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 40. AMERICAS BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 41. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. BRAZIL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. CANADA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. MEXICO BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 47. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 48. UNITED STATES BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 49. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 51. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 52. ASIA-PACIFIC BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 53. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. CHINA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. INDIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. INDONESIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. JAPAN BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. TAIWAN BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. THAILAND BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. VIETNAM BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 68. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 69. DENMARK BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. EGYPT BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. FINLAND BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. FRANCE BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. GERMANY BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. ISRAEL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. ITALY BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. NIGERIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. NORWAY BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. POLAND BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. QATAR BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. RUSSIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. SPAIN BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. SWEDEN BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. TURKEY BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. GLOBAL BRAIN BIOMARKERS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 91. GLOBAL BRAIN BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 92. GLOBAL BRAIN BIOMARKERS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL BRAIN BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER ANALYZERS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TEST KITS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TEST KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE , 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE , BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE , BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HUNTINGTON'S DISEASE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MND & ALS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MND & ALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MND & ALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 66. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. CANADA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 69. CANADA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. CHINA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 93. CHINA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. CHINA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. CHINA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 96. CHINA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. INDIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 98. INDIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. INDIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. INDIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 101. INDIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. JAPAN BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 108. JAPAN BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. JAPAN BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. JAPAN BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 111. JAPAN BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 138. THAILAND BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. THAILAND BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. THAILAND BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 141. THAILAND BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 154. DENMARK BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. DENMARK BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 157. DENMARK BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. EGYPT BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 159. EGYPT BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. EGYPT BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. EGYPT BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. FINLAND BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 164. FINLAND BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. FINLAND BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. FINLAND BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 167. FINLAND BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. GERMANY BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 174. GERMANY BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. GERMANY BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. GERMANY BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 177. GERMANY BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. ITALY BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 184. ITALY BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. ITALY BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. ITALY BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 187. ITALY BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. NIGERIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 194. NIGERIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. NIGERIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. NIGERIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 197. NIGERIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. NORWAY BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 199. NORWAY BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. NORWAY BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. NORWAY BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 202. NORWAY BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. POLAND BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 204. POLAND BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. POLAND BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. POLAND BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 207. POLAND BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. QATAR BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 209. QATAR BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. QATAR BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. QATAR BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 212. QATAR BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. SPAIN BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 229. SPAIN BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. SPAIN BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. SPAIN BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 232. SPAIN BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 239. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 241. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 242. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. TURKEY BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 244. TURKEY BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. TURKEY BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. TURKEY BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 247. TURKEY BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 254. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 256. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. GLOBAL BRAIN BIOMARKERS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 259. GLOBAL BRAIN BIOMARKERS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 260. GLOBAL BRAIN BIOMARKERS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 261. GLOBAL BRAIN BIOMARKERS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 262. GLOBAL BRAIN BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 263. GLOBAL BRAIN BIOMARKERS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 264. GLOBAL BRAIN BIOMARKERS MARKET MERGER & ACQUISITION
TABLE 265. GLOBAL BRAIN BIOMARKERS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 266. GLOBAL BRAIN BIOMARKERS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 267. GLOBAL BRAIN BIOMARKERS MARKET INVESTMENT & FUNDING
TABLE 268. GLOBAL BRAIN BIOMARKERS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 269. GLOBAL BRAIN BIOMARKERS MARKET: LICENSE & PRICING

Companies Mentioned

  • Advanced Brain Monitoring, Inc
  • Biognosys AG
  • BrainScope Company, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Johnson & Johnson
  • Lifesign LLC
  • Magstim EGI
  • Merck KGaA,
  • Natus Medical Inc.
  • NeuroVista Corporation
  • Nexus-DX
  • PhenoSwitch Bioscience
  • Seimens Healthnineers
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...